Risk of Suicide From GLP-1 Agonists: Weighing Risks and Benefits.
- Published in:
- Psychiatric Annals, 2024, v. 54, n. 9, p. e246, doi. 10.3928/00485713-20240916-01
- By:
- Publication type:
- Article
Works matching IS 00485713 AND DT 2024 AND VI 54 AND IP 9
Results: 6
1
2
Interventions to Enhance Neurocognition for Common Mental Disorders: A Brief Review.
- Published in:
- Psychiatric Annals, 2024, v. 54, n. 9, p. e263, doi. 10.3928/00485713-20240918-02
- By:
- Publication type:
- Article
3
Psychosocial and Psychopharmacological Interventions for Comorbid Bipolar Disorder and Substance Use Disorders: A Review.
- Published in:
- Psychiatric Annals, 2024, v. 54, n. 9, p. e258, doi. 10.3928/00485713-20240918-01
- By:
- Publication type:
- Article
4
Co-occurring Depression and Substance Use Disorders in Young People.
- Published in:
- Psychiatric Annals, 2024, v. 54, n. 9, p. e253, doi. 10.3928/00485713-20240913-03
- By:
- Publication type:
- Article
5
Clinical Screening and Assessment Considerations for Comorbid Substance Use Disorders in Adolescents With Mood Disorders.
- Published in:
- Psychiatric Annals, 2024, v. 54, n. 9, p. e248, doi. 10.3928/00485713-20240913-02
- By:
- Publication type:
- Article
6
Assessment and Treatment of Mood Disorders and Comorbid Substance Use.
- Published in:
- Psychiatric Annals, 2024, v. 54, n. 9, p. e247, doi. 10.3928/00485713-20240913-01
- By:
- Publication type:
- Article